当前位置:首页 - 行情中心 - 冠昊生物(300238) - 财务分析

冠昊生物

(300238)

  

流通市值:37.01亿  总市值:37.02亿
流通股本:2.65亿   总股本:2.65亿

冠昊生物(300238)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润0.21亿元,每股收益0.10元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益47107.38万元,未分配利润-31982.78万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产73032.00万元,负债25924.62万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入278,135,520.4189,698,181.6191,441,252.36404,178,697.25
营业总成本249,921,949.86160,966,865.6171,751,172.33360,489,232.61
营业利润31,497,237.7126,056,317.7920,520,473.3933,988,561.8
利润总额31,333,997.9525,878,411.9620,480,417.8832,089,194.46
净利润20,658,923.316,759,336.2315,474,779.8421,072,537.52
其他综合收益-112,095.04-41,348.81-80,925.934,244,210.95
综合收益总额20,546,828.2616,717,987.4215,393,853.9125,316,748.47
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计273,614,308.84265,232,317.14274,841,498.16267,277,868.72
非流动资产合计456,705,730.69429,514,778.89417,526,458.27411,317,030.68
资产总计730,320,039.53694,747,096.03692,367,956.43678,594,899.4
流动负债合计164,287,752.35148,458,456.94149,429,777.9172,716,216.73
非流动负债合计94,958,477.3780,391,769.0471,284,078.8749,618,436.92
负债合计259,246,229.72228,850,225.98220,713,856.77222,334,653.65
归属于母公司股东权益合计546,408,981.61538,791,833.64534,904,427.93520,593,839.11
股东权益合计471,073,809.81465,896,870.05471,654,099.66456,260,245.75
负债和股东权益合计730,320,039.53694,747,096.03692,367,956.43678,594,899.4
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计323,070,746.17212,016,517.0299,050,081.27444,178,639.41
经营活动现金流出小计290,728,712.46177,237,462.7888,179,541.29390,028,811.48
经营活动产生的现金流量净额32,342,033.7134,779,054.2410,870,539.9854,149,827.93
投资活动现金流入小计278,066.88138,970.36-2,808,571
投资活动现金流出小计60,133,403.0952,244,830.7234,622,805.3653,918,686
投资活动产生的现金流量净额-59,855,336.21-52,105,860.36-34,622,805.36-51,110,115
筹资活动现金流入小计72,000,00034,000,00024,000,00037,500,000
筹资活动现金流出小计36,214,956.1611,818,466.468,209,683.3164,824,101.12
筹资活动产生的现金流量净额35,785,043.8422,181,533.5415,790,316.69-27,324,101.12
汇率变动对现金及现金等价物的影响-30,661.7461,941.5-26,824.2777,012.71
现金及现金等价物净增加额8,241,079.64,916,668.92-7,988,772.96-24,207,375.48
期末现金及现金等价物余额104,349,485.07101,025,074.3988,119,632.5196,108,405.47
TOP↑